Stay updated on Pembrolizumab in Thymic Tumors Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Thymic Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Thymic Tumors Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    The page footer now displays Revision: v3.5.0, replacing the previous Revision: v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-25T20:24:45.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    A new publication citation was added to Publications, and an erratum citation was removed.
    Difference
    0.1%
    Check dated 2026-03-18T14:39:44.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-11T14:50:39.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Added a new publication citation on PD-1 therapy in solid tumors and removed the previous citation.
    Difference
    0.1%
    Check dated 2026-02-25T06:58:34.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added. A funding-status notice and the previous v3.4.1 revision were removed; these are administrative updates that do not affect study data or how to use the page.
    Difference
    0.5%
    Check dated 2026-02-11T02:37:13.000Z thumbnail image
  8. Check
    69 days ago
    Change Detected
    Difference
    0.5%
    Check dated 2026-02-03T23:47:38.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Thymic Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Thymic Tumors Clinical Trial page.